These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25561030)

  • 1. Genetic characterisation of drug resistance and clonal dynamics of Acinetobacter baumannii in a hospital setting in Mexico.
    Bocanegra-Ibarias P; Peña-López C; Camacho-Ortiz A; Llaca-Díaz J; Silva-Sánchez J; Barrios H; Garza-Ramos U; Rodríguez-Flores AM; Garza-González E
    Int J Antimicrob Agents; 2015 Mar; 45(3):309-13. PubMed ID: 25561030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evolution multi-drug resistant Acinetobacter baumannii by pulsed-field gel electrophoresis.
    Mohajeri P; Farahani A; Feizabadi MM; Norozi B
    Indian J Med Microbiol; 2015; 33(1):87-91. PubMed ID: 25560008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
    Lee MH; Chen TL; Lee YT; Huang L; Kuo SC; Yu KW; Hsueh PR; Dou HY; Su IJ; Fung CP
    J Microbiol Immunol Infect; 2013 Dec; 46(6):419-24. PubMed ID: 23010539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates.
    Lukovic B; Gajic I; Dimkic I; Kekic D; Zornic S; Pozder T; Radisavljevic S; Opavski N; Kojic M; Ranin L
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):101. PubMed ID: 32631451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of OXA-23 and OXA-58 Carbapenemases Coexpressed in Clinical Isolates of Acinetobacter baumannii in Tunisia.
    Mathlouthi N; Ben Lamine Y; Somai R; Bouhalila-Besbes S; Bakour S; Rolain JM; Chouchani C
    Microb Drug Resist; 2018 Mar; 24(2):136-141. PubMed ID: 28691891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
    Lowings M; Ehlers MM; Dreyer AW; Kock MM
    BMC Infect Dis; 2015 Nov; 15():521. PubMed ID: 26573617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nursing Home as a Reservoir of Carbapenem-Resistant Acinetobacter baumannii.
    Bedenić B; Beader N; Godič-Torkar K; Vranić-Ladavac M; Luxner J; Veir Z; Grisold AJ; Zarfel G
    Microb Drug Resist; 2015 Jun; 21(3):270-8. PubMed ID: 25599131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
    Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
    J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
    Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
    Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using bla(OXA-51-like) sequence based typing.
    Rafei R; Pailhoriès H; Hamze M; Eveillard M; Mallat H; Dabboussi F; Joly-Guillou ML; Kempf M
    BMC Microbiol; 2015 May; 15():103. PubMed ID: 25976451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage.
    Shrestha S; Tada T; Miyoshi-Akiyama T; Ohara H; Shimada K; Satou K; Teruya K; Nakano K; Shiroma A; Sherchand JB; Rijal BP; Hirano T; Kirikae T; Pokhrel BM
    Int J Antimicrob Agents; 2015 Nov; 46(5):526-31. PubMed ID: 26362951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
    Agodi A; Voulgari E; Barchitta M; Quattrocchi A; Bellocchi P; Poulou A; Santangelo C; Castiglione G; Giaquinta L; Romeo MA; Vrioni G; Tsakris A
    J Hosp Infect; 2014 Apr; 86(4):260-6. PubMed ID: 24680473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
    Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
    Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil.
    Carvalho KR; Carvalho-Assef AP; Peirano G; Santos LC; Pereira MJ; Asensi MD
    Int J Antimicrob Agents; 2009 Jul; 34(1):25-8. PubMed ID: 19216059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.